|
|
|
|
| LEADER |
00000cam a22000007a 4500 |
| 001 |
SCIDIR_on1379446863 |
| 003 |
OCoLC |
| 005 |
20231120010740.0 |
| 006 |
m o d |
| 007 |
cr un|---aucuu |
| 008 |
230523s2023 xx o 000 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|c YDX
|d OPELS
|d UKMGB
|d UKAHL
|d OCLCO
|
| 015 |
|
|
|a GBC376472
|2 bnb
|
| 016 |
7 |
|
|a 021026892
|2 Uk
|
| 019 |
|
|
|a 1379487720
|a 1379492228
|
| 020 |
|
|
|a 9780323999427
|q (electronic bk.)
|
| 020 |
|
|
|a 0323999425
|q (electronic bk.)
|
| 020 |
|
|
|z 9780323998734
|
| 020 |
|
|
|z 0323998739
|
| 035 |
|
|
|a (OCoLC)1379446863
|z (OCoLC)1379487720
|z (OCoLC)1379492228
|
| 050 |
|
4 |
|a RC280.B7
|
| 082 |
0 |
4 |
|a 616.99481
|2 23/eng/20230615
|
| 245 |
0 |
0 |
|a New insights into glioblastoma :
|b diagnosis, therapeutics and theranostics /
|c edited by Carla Vitorino, Carmen Balana and C�elia Cabral.
|
| 260 |
|
|
|a [S.l.] :
|b Academic Press,
|c 2023.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|2 rdacontent
|
| 336 |
|
|
|a still image
|2 rdacontent
|
| 337 |
|
|
|a computer
|2 rdamedia
|
| 338 |
|
|
|a online resource
|2 rdacarrier
|
| 505 |
0 |
|
|a <P><b>I. Introduction </b>1 Introduction: A brief outlook into glioblastoma diagnosis and therapeutics</p> <p><b>II. Diagnosis </b><i>II.1 Biomarkers </i>2. Practice guidelines for the diagnosis of glioblastoma 3. Identification of potential biomarkers in glioblastoma through OMICS technologies and Big Data Analysis 4. Forging a path to the use of liquid biopsy in the diagnosis of gliomas 5. Secretome analysis of patient-derived glioblastoma cells for potential biomarker identification <i>II.2 Techniques: updates </i>6. Newly diagnosed glioblastoma: a review on clinical management 7. Current status in brain glioma imaging (MRI, CT-Scan) 8. Combined PET/MRI in brain glioma imaging 9. New surgical approaches in glioblastoma 10. The role of radiogenomics</p> <p><b>III. Therapeutics </b><i>III.1 New chemical entities </i>11. An overview of molecular targeting of glioblastoma 12. Terpenes: a hope for glioblastoma patients 13. The artificial intelligence contribution to speed-up the active compounds screening 14. Repurposing drugs in glioblastoma 15. Glioblastoma heterogeneity and resistance: a glance in biology and therapeutic approach 16. Targeting DNA damage response pathways in glioblastoma: from mechanistic insights to advances in the clinic 17. Alkaloids: their relevance in cancer treatment <i>III.2 New formulation approaches </i>18. An overview of current drug delivery strategies for glioblastoma treatments and barriers to progress 19. Nanotechnology-based approaches in glioblastoma treatment: how can the dual blood brain/tumor barriers be overcome? 20. Non-coding RNAs in glioblastoma at a glance 21. The role of vaccines in glioblastoma -- updated clinical results 22. Dendritic cells and glioblastoma 23. Cancer stem cells in glioblastoma -- an update 24. Optimizing the role of immunotherapy for treatment of glioblastoma 25. The role of exosomes in glioblastoma treatment</p> <p><b>IV. Theranostics </b>26. Theranostic in glioblastoma 27. Potential theranostic targets in glioblastoma 28. Radiopharmaceuticals for molecular imaging and theranostics of glioblastoma 29. Theranostic strategies synergistically potentiate glioblastoma treatment via nanotechnology 30. The effect of glioblastoma microenvironment on theranostics</p>
|
| 650 |
|
0 |
|a Glioblastoma multiforme
|x Diagnosis.
|
| 650 |
|
0 |
|a Glioblastoma multiforme
|x Treatment.
|
| 650 |
|
6 |
|a Glioblastome
|0 (CaQQLa)201-0227421
|x Traitement.
|0 (CaQQLa)201-0377521
|
| 700 |
1 |
|
|a Vitorino, Carla.
|
| 700 |
1 |
|
|a Balana, Carmen.
|
| 700 |
1 |
|
|a Cabral, C�elia.
|
| 776 |
0 |
8 |
|i ebook version :
|z 9780323999427
|
| 776 |
0 |
8 |
|c Original
|z 0323998739
|z 9780323998734
|w (OCoLC)1348633600
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780323998734
|z Texto completo
|
